论文部分内容阅读
目的:研究分析氨溴索联合抗生素治疗老年糖尿病合并肺炎的临床效果。方法:根据我院2015年8月至2016年8月接收的86例糖尿病合并肺炎患者入院时间先后分为对照组和观察组。对照组患者单独使用抗生素治疗,观察组患者则应用氨溴索与抗生素治疗。对比两组患者临床治疗效率。结果:观察分析观察组和对照组治疗期间不良反应,并无明显差异(P>0.05);对照组和观察组临床治疗效率分别为74.4%和93.0%,两组患者临床治疗效率差异显著(P<0.05);对比分析两组患者临床症状改善时间与住院时间,均表明观察组患者时间均短于对照组,差异显著(P<0.05)。结论:相对比单独使用抗生素治疗,老年糖尿病合并肺炎患者使用氨溴索和抗生素进行治疗,疗效更确切,更有助于改善患者临床症状,且安全系数相对较高,可在临床上推广应用。
Objective: To study the clinical effect of ambroxol combined with antibiotics in the treatment of senile diabetes mellitus complicated with pneumonia. Methods: According to our hospital from August 2015 to August 2016 received 86 cases of diabetic patients with pneumonia admission time has been divided into control group and observation group. Patients in the control group were treated with antibiotics alone and patients in the observation group were treated with ambroxol and antibiotics. Compare the clinical treatment efficiency of two groups of patients. Results: There was no significant difference between the observation group and the control group during the treatment (P> 0.05). The clinical efficacies of the control group and the observation group were 74.4% and 93.0%, respectively, and there was significant difference between the two groups <0.05). Comparing the clinical symptom improvement time and hospitalization time of the two groups showed that the time of the observation group was shorter than that of the control group (P <0.05). Conclusion: Compared with antibiotic alone, elderly patients with diabetes mellitus and pneumonia treated with ambroxol and antibiotics are more effective and more helpful to improve the clinical symptoms of patients. The safety factor is relatively high and can be widely used clinically.